Binge Eating Disorder

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Lannett Company, Inc.)

  FDA approves the original application for lisdexamfetamine dimesylate as a generic drug by Lannett Company, enabling generic supply with the…

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA lists Camber Pharmaceuticals' lisdexamfetamine dimesylate as an approved original application (generic) product. The approval covers the…

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal Pharmaceuticals LLC's original application for lisdexamfetamine dimesylate as a generic drug. This approval provides a g…

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Apotex Corp.)

  FDA approves Apotex Corp.'s lisdexamfetamine dimesylate as a generic version of the ADHD and binge eating disorder medication.

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a generic lisdexamfetamine dimesylate product under an Original ANDA for the treatment of ADHD and binge-eating disorder.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Solco Healthcare US,LLC)

  FDA approved Solco Healthcare US, LLC's lisdexamfetamine dimesylate capsules as an original generic application (ANDA) for ADHD and binge ea…

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approves Sun Pharmaceutical's lisdexamfetamine dimesylate as an original generic application, confirming a generic version of the stimul…

• FDA approval · 2023-08-25
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Teva Pharmaceuticals, Inc.)

  FDA approves lisdexamfetamine dimesylate as an Original Application (ANDA) for Teva Pharmaceuticals, providing a generic option for the ADHD…

• FDA approval · 2022-02-25
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc., indicating …

• FDA approval · 2021-11-02
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2017-07-31
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc., providing a…

• FDA approval · 2017-01-06
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2016-04-15
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc. unde…

• FDA approval · 2015-12-04
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2015-01-30
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2012-11-19
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc., res…

• FDA approval · 2011-03-16
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc.

• FDA approval · 2010-11-10
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America.

• FDA approval · 2010-04-05
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental NDA for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, detailing a label/indication …

• FDA approval · 2009-05-22
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc., authorizing cha…